Aspirin News and Research

RSS

Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.

Daily aspirin can reduce risk of colorectal cancer in adults

Regular aspirin use has clear benefits in reducing colorectal cancer incidence among middle-aged adults, but also comes with some risk, such as gastrointestinal bleeding. And when should adults start taking regular aspirin and for how long?

22 Jan 2021

Researchers discover novel therapeutic strategy for ischemic stroke using experimental model

Research conducted at LSU Health New Orleans Neuroscience Center of Excellence reports that a combination of an LSU Health-patented drug and selected DHA derivatives is more effective in protecting brain cells and increasing recovery after stroke than a single drug. The findings are published in Brain Circulation, available here.

4 Jan 2021

Study examines sex differences in the cause of death after stroke

Women were 39% more likely to die by 1 year after a first stroke. The sex difference was due to advanced age and more severe strokes in women, according to a new study in the Journal of Women's Health.

23 Dec 2020

High altitude experts explain pneumolysis caused by COVID-19

The current COVID-19 pandemic has caused over 1 million deaths which can be attributed to its severe progressive pulmonary compromise.

21 Dec 2020

Azithromycin trial fails to provide evidence of benefit in COVID-19

Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.

16 Dec 2020

Neutrophils may play a key role in COVID-19-related thrombosis

A team of researchers in Italy have published a study suggesting that rather than platelets, neutrophils could be playing the lead role in thrombotic complications associated with COVID-19.

9 Dec 2020

Lipid storm in severe COVID-19 linked to high COX/LOX pathway activity

A potentially valuable new study discusses the role of lipids in the hyper-inflammatory phenomena that take place within the lungs of patients with severe or critical COVID-19. Involving a large variety of specialized lipids with biological activity, this process includes the generation and release of pro and anti-inflammatory lipids.

8 Dec 2020

Could beta-blockers be a potential treatment for COVID-19?

News-Medical spoke to researchers about their latest research into beta-blockers, and how they could potentially be used to treat COVID-19.

27 Nov 2020

International trialists receive prestigious award for research on low-dose aspirin

The international trialists Professors Lars Wallentin, Jan van Gijn, Bo Norrving and Tom Meade were recognized for their work on low-dose aspirin, with the presentation of the International Aspirin Foundation Senior Science Award.

22 Nov 2020

UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients

The University of Illinois Chicago will conduct three clinical trials for studying blood clot prevention in patients with COVID-19.

18 Nov 2020

Combination of ticagrelor and aspirin reduces subsequent stroke risk in patients with heart plaque

Patients with plaque build-up in their arteries, who suffered a transient ischemic attack (TIA) or a minor ischemic stroke, also called a warning stroke, and were treated with the newer blood thinner ticagrelor plus aspirin were 27% less likely to have another stroke within 30 days, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Heart attacks, strokes and other cardiovascular incidents can be cut by 20 to 40 per cent through use of a polypill which combines three blood pressure medications and a lipid lowering medication taken alone or with aspirin.

16 Nov 2020

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

A one-month treatment of dual anti-platelet therapy is safe and as effective as a longer duration of therapy at preventing cardiac events in patients one year after stent placement, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

The use of the more potent antiplatelet medication ticagrelor was not superior to clopidogrel in the reduction of the rate of heart attack or severe complications among people undergoing an elective procedure to open a blocked artery, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

A single, daily pill combining blood pressure and cholesterol medications, along with the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to late-breaking research presented today in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

A promising vaccine for treating poorly immunogenic tumors

Patients with cancer have multiple treatment options available to them today, but each has its drawbacks. Chemotherapy kills rapidly dividing cancer cells, but it also damages healthy cells in the body and often does not effectively prevent tumor metastasis or disease recurrence.

11 Nov 2020

Aspirin to be tested as a potential COVID-19 treatment as part of RECOVERY trial

Now, in new research, the everyday painkiller aspirin will be evaluated as a potential treatment for COVID-19 in one of the United Kingdom’s most significant trials, aiming to evaluate whether it can reduce the risk of blood clots in infected people.

9 Nov 2020

CAC scanning can help doctors decide which patients might benefit from aspirin therapy

An X-ray test commonly used to assess hardening of the arteries could help doctors decide whether the benefits of taking aspirin to prevent a first heart attack or stroke outweigh the risks of bleeding from its use, UT Southwestern research suggests.

28 Oct 2020

Aspirin use associated with reduced mortality risk in hospitalized COVID-19 patients

Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine.

22 Oct 2020

FDA warns women about the risks of using NSAIDs in the second half of pregnancy

The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring labeling changes for nonsteroidal anti-inflammatory drugs (NSAIDs).

15 Oct 2020

Aspirin News and Research

Further Reading

Daily aspirin can reduce risk of colorectal cancer in adults

Researchers discover novel therapeutic strategy for ischemic stroke using experimental model

Study examines sex differences in the cause of death after stroke

High altitude experts explain pneumolysis caused by COVID-19

Azithromycin trial fails to provide evidence of benefit in COVID-19

Neutrophils may play a key role in COVID-19-related thrombosis

Lipid storm in severe COVID-19 linked to high COX/LOX pathway activity

Could beta-blockers be a potential treatment for COVID-19?

International trialists receive prestigious award for research on low-dose aspirin

UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients

Combination of ticagrelor and aspirin reduces subsequent stroke risk in patients with heart plaque

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

A promising vaccine for treating poorly immunogenic tumors

Aspirin to be tested as a potential COVID-19 treatment as part of RECOVERY trial

CAC scanning can help doctors decide which patients might benefit from aspirin therapy

Aspirin use associated with reduced mortality risk in hospitalized COVID-19 patients

FDA warns women about the risks of using NSAIDs in the second half of pregnancy

PromoCell's New GMP Certification - EXCiPACT

Treating post-infectious smell loss in COVID-19 patients

A paper-based sensor for detecting COVID-19

Latest News